Alfacell Corp (NASDAQOTH:ACEL.PK)

CAPS Rating: No stars

A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.

Recs

1
Player Avatar mojoo (< 20) Submitted: 4/22/2007 8:10:37 AM : Outperform Start Price: $2.78 ACEL.PK Score: -92.51

heal

Featured Broker Partners


Advertisement